Bodies of desire: use of nonprescribed hormones among transgender women and travestis in five Brazilian capitals (2019-2021).

Autor:	Bassichetto KC; Santa Casa de São Paulo, School of Medical Sciences - São Paulo (SP), Brazil., Pinheiro TF; Santa Casa de São Paulo, School of Medical Sciences - São Paulo (SP), Brazil., Barros C; Secretaria de Estado da Saúde de São Paulo, Butantan Institute - São Paulo (SP), Brazil., Fonseca PAM; Fiocruz Amazônia,. Leônidas and Maria Deane Institute - Manaus (AM), Brasil., Queiroz RSB; Fiocruz Amazônia,. Leônidas and Maria Deane Institute - Manaus (AM), Brasil., Sperandei S; Western Sydney University, Translational Health Research Institute - Sydney (NSW), Australia., Veras MASM; Santa Casa de São Paulo, School of Medical Sciences - São Paulo (SP), Brazil.
Jazyk:	English; Portuguese
Zdroj:	Revista brasileira de epidemiologia = Brazilian journal of epidemiology [Rev Bras Epidemiol] 2024 Aug 19; Vol. 27Suppl 1 (Suppl 1), pp. e240010.supl.1. Date of Electronic Publication: 2024 Aug 19 (Print Publication: 2024).
DOI:	10.1590/1980-549720240010.supl.1
Abstrakt:	Objective: To analyze the experiences of transgender women and travestis regarding the use of hormones for body changes without a medical prescription. Methods: This is a cross-sectional, quantitative and qualitative study, using data from "TransOdara", which estimated the prevalence of Sexually Transmitted Infections in transgender women and travestis recruited through Respondent-Driven Sampling, between December 2019 and July 2021, in São Paulo, Campo Grande, Manaus, Porto Alegre, and Salvador, Brazil. The main outcome was: use of hormones without medical prescription and associated risk factors. Descriptive analysis, mixed univariate logistic regression models, and semi-structured interviews were carried out. Results: Of the 1,317 recruited participants, 85.9% had already used hormones. The current use of hormones was reported by 40.7% (536) of them. Of those who were able to inform the place where they obtained them, 72.6% (381/525) used them without a medical prescription. The variables associated with the outcome were: current full-time sex work (OR 4.59; 95%CI 1.90-11.06) or in the past (OR 1.92; 95%CI 1.10-3.34), not having changed their name (OR 3.59; 95%CI 2.23-5.76), not currently studying (OR 1.83; 95%CI 1.07-3.13), being younger (OR 2.16; 95%CI 1.31-3.56), and having suffered discrimination at some point in life for being a transgender women and travestis (OR 0.40; 95%CI 0.20-0.81). Conclusion: The use of nonprescribed hormones is high among transgender women and travestis, especially among those who are younger, did not study, have not changed their name, and with a history of sex work. This use is related to the urgency for gender transition, with excessive use and damage to health.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu